Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes - Concepedia

Concepedia

Publication | Closed Access

Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes

150

Citations

36

References

2017

Year

Ginger Smith Carls, Edward Tuttle, Ruoding Tan, Johnny Huynh, John Yee, Steven V. Edelman, William H. Polonsky

Abstract

Poor medication adherence is primarily why RW effectiveness is significantly less than RCT efficacy, suggesting an urgent need to effectively address adherence among patients with type 2 diabetes.

References

	Year	Citations

Page 1